The recent disruptions in global chains have highlighted the value of securing critical medications like Ivermectin. Trusting on overseas producers exposes regions to significant vulnerabilities, including delivery delays, cost fluctuations, and even political concerns. Moving towards domestic procurement of Ivermectin offers a multitude of upsides